Novo CEO pressed by Senate to chop costs of obesity, diabetes medication CEO Lars Fruergaard Jørgensen instructed lawmakers the business would take into consideration new talks with insurers with regard to the record rates of Wegovy and copyright whenever they pledge to keep the medicines on their own formularies. Where https://daveshotchickennutrition19641.blogdeazar.com/30777511/not-known-factual-statements-about-healthcare-news